A detailed history of Eco R1 Capital, LLC transactions in Galapagos Nv stock. As of the latest transaction made, Eco R1 Capital, LLC holds 155,006 shares of GLPG stock, worth $4.22 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
155,006
Previous 5,756,268 97.31%
Holding current value
$4.22 Million
Previous $143 Million 96.87%
% of portfolio
0.19%
Previous 5.04%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$24.2 - $30.67 $136 Million - $172 Million
-5,601,262 Reduced 97.31%
155,006 $4.46 Million
Q2 2023

Aug 14, 2023

BUY
$37.4 - $44.52 $56.5 Million - $67.3 Million
1,511,623 Added 35.61%
5,756,268 $234 Million
Q1 2023

May 15, 2023

BUY
$36.5 - $48.0 $18.8 Million - $24.7 Million
513,915 Added 13.78%
4,244,645 $164 Million
Q4 2022

Feb 14, 2023

BUY
$37.44 - $46.51 $20 Million - $24.8 Million
533,230 Added 16.68%
3,730,730 $166 Million
Q2 2022

Aug 15, 2022

BUY
$52.3 - $71.59 $98,114 - $134,302
1,876 Added 0.06%
3,197,500 $178 Million
Q1 2022

May 16, 2022

BUY
$51.32 - $68.5 $49.8 Million - $66.5 Million
971,221 Added 43.66%
3,195,624 $198 Million
Q4 2021

Feb 14, 2022

BUY
$47.03 - $57.12 $31.3 Million - $38 Million
665,654 Added 42.7%
2,224,403 $123 Million
Q3 2021

Nov 15, 2021

BUY
$52.17 - $70.2 $81.3 Million - $109 Million
1,558,749 New
1,558,749 $82 Million
Q1 2021

May 17, 2021

SELL
$76.15 - $111.94 $3.55 Million - $5.22 Million
-46,666 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$96.85 - $148.25 $4.52 Million - $6.92 Million
46,666 New
46,666 $4.62 Million
Q1 2018

May 15, 2018

SELL
$94.51 - $120.23 $10.4 Million - $13.3 Million
-110,384 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$84.48 - $104.02 $11 Million - $13.6 Million
-130,392 Reduced 54.15%
110,384 $10.4 Million
Q3 2017

Nov 14, 2017

BUY
$73.17 - $103.47 $17.6 Million - $24.9 Million
240,776
240,776 $24.5 Million

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.79B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Eco R1 Capital, LLC Portfolio

Follow Eco R1 Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eco R1 Capital, LLC with notifications on news.